Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
Application of Atomized Inhalation ICG in Thoracoscopic Surgery for Pulmonary Sequestration in Children: a Multicentre Prospective Study
Jiexiong Feng
50 participants
Mar 1, 2024
INTERVENTIONAL
Conditions
Summary
To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.
Eligibility
Inclusion Criteria1
- children with congenital lung malformations diagnosed by CT or MRI scan
Exclusion Criteria1
- \. ages <3 months and >14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Preoperative preparation ICG solution dissolved in 5ml of normal saline (dose 0.5mg/kg) was inhaled 30 minutes before surgery. Operation method After entering the chest cavity, the fluorescence endoscope was switched to the fluorescence display mode, and the fluorescence-stained normal lung tissue and non-stained lesion tissue could be clearly displayed through the display screen, and the external boundary of the lesion was marked with an electric hook. The mediastinal pleura and pulmonary pleura were opened along the boundary of the lesion, and the lung tissue was split along the gap between the lesion and the lung tissue with an electric coagulation hook and an ultrasonic knife, and the lesion arteries and bronchi were freed.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06302985